The CRC-bearing rats treated with PGPs-NE exhibited normalized metalloproteinase activity, stable biomarkers for cancer and inflammation, improved liver function, increased antioxidant levels, reduced levels of fragmented DNA, and PCNA expression. The gene discussed is PCNA; the disease is cancer.